lumbar
-
Spine
Centinel Spine’s Leadership in Lumbar Total Disc Replacement Fueled Through Rapidly Expanding Market and Long-Term Survivability Data
Centinel Spine remains the clear worldwide leader in the lumbar total disc replacement (LTDR) market1, and its prodisc L device is the…
Read More » -
Spine
Innovasis Inc. Announces Positive Clinical Outcomes, in the Global Spine Journal, from the BioBase® Data Registry.
Salt Lake City, Utah, August 20, 2024 /OrthoSpineNews/ – Innovasis Inc., a leader in spinal innovation and research, is pleased…
Read More » -
Spine
Landmark Study Shows Lumbar Facet Arthroplasty Superior to Fusion for Spinal Stenosis and Spondylolisthesis
Tim Allen, June 26th, 2024, OrthoSpineNews – A study published in the Journal of Bone and Joint Surgery has found…
Read More » -
Spine
ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
MISGAV, Israel, May 6, 2024 /PRNewswire/ — ZygoFix Ltd. a portfolio company of The Trendlines Group Ltd. (“Trendlines”) announced that it received regulatory clearance from the United…
Read More » -
Spine
MCRA Assists Curiteva Inc. with FDA 510(k) Clearance for Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System
WASHINGTON, Feb. 20, 2024 /PRNewswire/ — MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and…
Read More » -
Financial
New Study Reveals Cost-Effective Lumbar Facet Arthroplasty For Degenerative Spondylolisthesis And Stenosis
Premia Spine TOPS™ This study demonstrates the TOPS device’s continued cost-effectiveness and immediate dominance compared to TLIF, making it a…
Read More » -
Spine
BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
— Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial — — Company…
Read More » -
Spine
Providence Medical Technology Announces FDA Clearance of CAVUX® FFS-LX Lumbar Facet Fixation System for 1- and 2-Level Lumbar Spinal Fusion
CAVUX FFS-LX Achieved 96% Fusion Rate Verified by Independent Core Imaging Lab in Recent Clinical Study PLEASANTON, Calif., Jan. 11, 2024 /PRNewswire/…
Read More » -
Biologics
Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion
If approved, the breakthrough product will bring Cerapedics’ P-15 Peptide to lumbar spine fusion with a TLIF indication, making it…
Read More » -
Spine
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis
LEWISVILLE, Texas, December 21, 2023–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the publication…
Read More » -
Spine
MiRus Announces FDA 510(k) Clearance for Molybdenum-Rhenium (MoRe®) Low Profile Anterior Cervical and Lateral Lumbar Plating Systems
ATLANTA, Oct. 18, 2023 /PRNewswire/ — MiRus® announced that it has received FDA 510(k) clearance of the CYGNUS™ MoRe® Anterior Cervical Plate…
Read More » -
Spine
Captiva Spine Completes WatchTower Spine Navigation System’s First ASC 3D Navigated MIS Pedicle Screw Series in the U.S. Using 2D Percutaneous Registration
WatchTower™ SNS – Spine Navigation System: Elevating Spinal Procedures with Breakthrough Technology. October 17, 2023 / OrthoSpineNews/ – Captiva Spine®, a…
Read More » -
Spine
Centinel Spine Surgical Stadium Event at NASS 2023 to Demonstrate Value of prodisc® Match-the-Disc™ Cervical and Lumbar Total Disc Replacement Systems
Centinel Spine is the only company to offer cervical and lumbar total disc replacement (TDR) systems that allow matching the…
Read More » -
Biologics
BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
–Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— –15 Clinical Sites Identified, 12…
Read More » -
Biologics
BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease
—Clinical data expected to be reviewed by independent data safety monitoring board (DSMB) as to initial safety dosing profile of BRTX-100– MELVILLE,…
Read More »